'There were 44 (21.6%) patients with cardiovascular diseases, 24 (11.8%) patients with endocrine system diseases, and others with respiratory diseases (9 [4.4%]), malignant tumors (13 [6.3%]) and other disorders as shown in Table 1. After admission, there were 184 (90.2%) patients receiving antiviral treatment (e.g., lopinavir-ritonavir), 141(69.1%) on antibiotics, 80 (39.2%) on glucocorticoids, 96 (47.1%) on nebulized α-interferon, 56 (27.5%) on intravenous immunoglobulin, and 10 (4.9%) on antifungal treatment. Additionally, 16 patients were transferred to the ICU (7.8%), 168 were discharged (82.4%), and 37(17.7%) died. Among the patients, the average hospital stay was 17 days (SD +9.0), and the average length of stay in the ICU was 8.9 days (SD +6.9). '